2-METHYL-6,7-DIMETHOXY-1,2-BENZOTHIAZIN-3-ONE-4-(3',5'-DITERT.-BUTYL-4'-HYDROXYBENZYLIDENE)-1,1-DIOXIDE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | LgOUcoM6PxS |
|---|---|
| InChI | InChI=1S/C26H33NO6S/c1-25(2,3)18-11-15(12-19(23(18)28)26(4,5)6)10-17-16-13-20(32-8)21(33-9)14-22(16)34(30,31)27(7)24(17)29/h10-14,28H,1-9H3/b17-10- |
| InChIKey | YCARYEBNKNHDCH-YVLHZVERSA-N |
| Mol Weight | 487.6 g/mol |
| Molecular Formula | C26H33NO6S |
| Exact Mass | 487.202859 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
Dimethyl 2,6-Bis[3,4-(dimethoxy)phenyl]-3,7-dioxobicyclo[3.3.0]octane-2,6-dicarboxylate
2-[2-[(tert-Butoxycarbonyl)amino]-6-methoxy-4-methylphenyl]-5-methoxy-1,4-naphthoquinone
N-(3-acetylphenyl)-2-(5-methoxy-4,8,8-trimethyl-2-oxo-2,8,9,10-tetrahydropyrano[2,3-f]chromen-3-yl)acetamide
1H,5H,11H-[1]benzopyrano[6,7,8-ij]quinolizine-10-carboxamide, 2,3,6,7-tetrahydro-11-imino-N-(2-methoxy-5-methylphenyl)-
9,9-Dimethyl-2,2,4,6,6-penta(2'-naphthyl)-3,5,8,10-tetraoxa-4-phosphabicyclo[5.3.0]decane
3-[(2,3-dimethoxyphenyl)(4-methyl-2-oxo-2H-chromen-3-yl)methyl]-4-methyl-2H-chromen-2-one
3,3'-bis(1"-Naphthylimino)-1,3,1',3'-tetrahydro-[2,2']-bis[benzo[g]indolylidene]
3-[2-methoxy-5-(4-morpholinylsulfonyl)phenyl]-6-methyl[1,2,4]triazolo[3,4-a]phthalazine
4-Cyano-1-oxo-N-(4-phenylthiazol-2-yl)-1H-pyrido[2,1-b]benzothiazole-2-carboxamide
ETHYL-3-AMINO-2-CYANO-5-[4-(DIMETHYLAMINO)-PHENYL]-7-METHYL-5H-THIAZOLO-[3,2-A]-PYRIMIDINE-6-CARBOXYLATE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of new 1,2-Benzothiazin-3-one Derivatives Designed as Dual Cyclooxygenase-2 and 5-Lipooxygenase Inhibitors | Journal of the Brazilian Chemical Society | 1998 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.